Mutations in TLR4 signaling that lead to increased susceptibility to infection in humans: an overview

Abstract

In this overview, we will present current information on known mutations in the TLR4 signaling pathway that have been associated with increased susceptibility to disease. To date, mutations in the extracellular domain of TLR4 itself, IRAK-4, NEMO (IKKγ), and IκBα have been identified and profoundly affect the host response to infection.

Keywords

TLR signaling LPS mutations

References

Akira S. , Takada K. Functions of Toll-like receptors: lesions from KO mice. C R Biol 2004; 327: 581—589.

Vogel SN , Fitzgerald KA , Fenton MJ TLRs: differential adapter utilization by Toll-like receptors mediates TLR-specific patterns of gene expression. Mol Intervent 2003; 3: 466—477.

Akira S. , Takeda K. Toll-like receptor signaling. Nat Rev Immunol 2004; 4: 499—511.

Sabroe I. , Read RC , Whyte MK , Dockrell DH , Vogel SN , Dower SK Toll-like receptors in health and disease: complex questions remain . J Immunol 2003; 171: 1630—1635.

Kurt-Jones EA , Popova L. , Kwinn L. et al. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat Immunol 2000; 1: 398—401.

Bulut Y. , Faure E. , Thomas L. , Karahashi H. , Michelsen kS , Equis O. et al. Chlamydial heat shock protein 60 activates macrophages and endothelial cells through Toll-like receptor 4 and MD2 in a MyD88-dependent pathway. J Immunol 2002; 168: 1435—1440.

Malley R. , Henneke P. , Morse SC et al. Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection. Proc Natl Acad Sci USA 2003; 100: 1966—1971.

Perera P-Y. , Mayadas TN , Takeuchi O. et al. CD11b/CD18 acts in concert with CD14 and Toll-like receptor (TLR) 4 to elicit full lipopolysaccharide and Taxol-inducible gene expression . J Immunol 2001; 166: 574—581.

Kawasaki K. , Akashi S. , Shimazu R. , Yoshida T. , Miyake K. , Nishijima M. Involvement of TLR4/MD-2 complex in species-specific lipopolysaccharide mimetic signal transduction by Taxol. J Endotoxin Res 2001; 7: 232—236.

10.

Tsan MF , Gao B. Endogenous ligands of Toll-like receptors. J Leukoc Biol 2004; 76: 514—519.

11.

Toshchakov V. , Jones BW , Perera PY et al. TLR4, but not TLR2, mediates IFN-beta-induced STAT1alpha/beta-dependent gene expression in macrophages. Nat Immunol 2002; 3: 392—398.

12.

Gao JJ , Diesl V. , Wittmann T. et al. Bacterial LPS and CpG DNA differentially induce gene expression profiles in mouse macrophages. J Endotoxin Res 2003; 9: 237—243.

13.

Bjorkbacka H. , Fitzgerald KA , Huet F. et al. The induction of macrophage gene expression by LPS predominantly utilizes MyD88-independent signaling cascades. Physiol Genomics 2004 ; 19: 319—330.

14.

Smirnova I. , Poltorak A. , Chan EK , McBride C. , Beutler B. Phylogenetic variation and polymorphism at the toll-like receptor 4 locus (TLR4). Genome Biol 2000; 1: RESEARCH002.

15.

Arbour NC , Lorenz E. , Schutte BC et al. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 2000; 25: 187—191.

16.

Raby BA , Klimecki WT , Laprise C. et al. Polymorphisms in Toll-like receptor 4 are not associated with asthma or atopy-related phenotypes. Am J Respir Crit Care Med 2002; 166: 1449—1456.

17.

Newport MJ , Allen A. , Awomoyi AA et al. The Toll-like receptor 4 Asp299Gly variant: no influence on LPS responsiveness or susceptibility to pulmonary tuberculosis in The Gambia . Tuberculosis (Edinb) 2004; 84: 347—352.

18.

Lorenz E. , Hallman M. , Marttila R. , Haataja R. , Schwartz DA Association between the Asp299Gly polymorphisms in the Toll-like receptor 4 and premature births in the Finnish population. Pediatr Res 2002; 52: 373—376.

19.

Tal G. , Mandelberg A. , Dalal I. et al. Association between common Toll-like receptor 4 mutations and severe respiratory syncytial virus disease. J Infect Dis 2004; 189: 2057—2063.

20.

Hartel CH , Finas D. , Ahrens P. et al. Genetic Factors in Neonatology Study Group. Polymorphisms of genes involved in innate immunity: association with preterm delivery. Mol Hum Reprod 2004; 10: 911—915.

21.

Lorenz E. , Schwartz DA , Martin PJ et al. Association of TLR4 mutations and the risk for acute GVHD after HLA-matched-sibling hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2001; 7: 384—387.

22.

Lorenz E. , Mira JP , Frees KL , Schwartz DA Relevance of mutations in the TLR4 receptor in patients with Gram-negative septic shock. Arch Intern Med 2002; 162: 1028—1032.

23.

Agnese DM , Calvano JE , Hahm SJ et al. Human Toll-like receptor 4 mutations but not CD14 polymorphisms are associated with an increased risk of Gram-negative infections. J Infect Dis 2002; 186: 1522—1525.

24.

Morre SA , Murillo LS , Spaargaren J. , Fennema HS , Pena AS Role of the Toll-like receptor 4 Asp299Gly polymorphism in susceptibility to Candida albicans infection. J Infect Dis 2002; 186: 1377—1379.

25.

Morre SA , Murillo LS , Bruggeman CA , Pena AS The role that the functional Asp299Gly polymorphism in the Toll-like receptor-4 gene plays in susceptibility to Chlamydia trachomatisassociated tubal infertility . J Infect Dis 2003; 187: 341—342.

26.

Genc MR , Vardhana S. , Delaney ML , Onderdonk A. , Tuomala R. , Norwitz E. , Witkin SS; MAP Study Group. Relationship between a Toll-like receptor-4 gene polymorphism, bacterial vaginosisrelated flora and vaginal cytokine responses in pregnant women. Eur J Obstet Gynecol Reprod Biol 2004 ; 116: 152—156.

27.

Read RC , Pullin J. , Gregory S. et al. A functional polymorphism of Toll-like receptor 4 is not associated with likelihood or severity of meningococcal disease. J Infect Dis 2001; 184: 640—642.

28.

Franchimont D. , Vermeire S. , El Housni H. et al. Deficient host-bacteria interactions in inflammatory bowel disease? The Toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitis . Gut 2004; 53: 987—992.

29.

Ohkusa T. , Nomura T. , Sato N. The role of bacterial infection in the pathogenesis of inflammatory bowel disease. Intern Med 2004; 43: 534—539.

30.

Kiechl S. , Lorenz E. , Reindl M. et al. Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med 2002; 347: 185—192.

31.

Edfeldt K. , Bennet AM , Eriksson P. et al. Association of hypo-responsive toll-like receptor 4 variants with risk of myocardial infarction. Eur Heart J 2004; 25: 1447—1453.

32.

Radstake TR , Franke B. , Hanssen S. et al. The Toll-like receptor 4 Asp299Gly functional variant is associated with decreased rheumatoid arthritis disease susceptibility but does not influence disease severity and/or outcome. Ann Rheum Dis 2004; 63: 696—702.

33.

Vogel SN , Bhat N. , Malo D. , Qureshi ST Genetic control of endotoxin responsiveness. In: Brade H , Opal SM , Vogel SN , Morrison DC. (eds) Endotoxin in Health and Disease. New York : Marcel Dekker, 1999; 735—750.

34.

Michelsen KS , Wong MH , Shah PK et al. Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. Proc Natl Acad Sci USA 2004; 101: 10679—10684.

35.

Suzuki N. , Suzuki S. , Duncan GS et al. Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4. Nature 2002; 416: 750—756.

36.

Picard C. , Puel A. , Bonnet M. et al. Pyogenic bacterial infections in humans with IRAK-4 deficiency . Science 2003; 299: 2076—2079.

37.

Medvedev AE , Lentschat A. , Kuhns DB et al. Distinct mutations in IRAK-4 confer hyporesponsiveness to lipopolysaccharide and interleukin-1 in a patient with recurrent bacterial infections. J Exp Med 2003; 198: 521—531.

38.

Currie AJ , Davidson DJ , Reid GS et al. Primary immunodeficiency to pneumococcal infection due to a defect in Toll-like receptor signaling. J Pediatr 2004; 144: 512—518.

39.

Kuhns DB , Long Priel DA , Gallin JI Endotoxin and IL-1 hyporesponsiveness in a patient with recurrent bacterial infections. J Immunol 1997; 158: 3959—3964.

40.

Puel A. , Yang K. , Ku C-L. et al. Heritable defects of the human TLR signaling pathways. J Endotoxin Res 2005; 220—224.

41.

Jacobs H. , Bross L. Towards an understanding of somatic hypermutation. Curr Opin Immunol 2001; 13: 208—218.

42.

Orange JS , Geha RS Finding NEMO: genetic disorders of NF-[kappa]B activation. J Clin Invest 2003; 112: 983—985.

43.

Puel A. , Picard C. , Ku CL , Smahi A. , Cassanova JL Inherited disorders of NF-kappaB-mediated immunity in man. Curr Opin Immunol 2004; 16: 34—41.

44.

Courtois G. , Smahi A. , Reichenbach J. et al. A hypermorphic IkappaBalpha mutation is associated with autosomal dominant anhidrotic ectodermal dysplasia and T cell immunodeficiency. J Clin Invest 2003 ; 112: 1108—1115.

45.

Medvedev AE , Thomas K. , Awomoyi A. , Kuhns DB , Gallin JI , Li X. , Vogel SN Cutting edge: expression of IL-1 receptor-associated kinase-4 (IRAK-4) proteins with mutations identified in a patient with recurrent bacterial infections alters IRAK-4 interaction with components of the IL-1 receptor complex. J Immunol 2005; 174: 6587—6591.